Published in Hepatitis Weekly, September 11th, 2000
Their conclusion is based on a study of a variety of pre-cancerous nodules and HCC tumors for the presence of antibodies against VEGF and other cell markers (Y.N. Park et al., "Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogenesis," Archives of Pathology and Laboratory Medicine, 2000;124(7):1061-1065).
In stating the thesis of the study, Y.N. Park and colleagues said, "Recent studies have reported...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2000-09-11)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.